title: Reactive oxygen and nitrogen metabolites modulate fibronectin-induced fibroblast migration in vitro.
abstract: Nitration of proteins by peroxynitrite may alter protein function. We hypothesized that reactive nitrogen species modulate fibronectin-induced fibroblast migration. To test this hypothesis, we evaluated fibroblast migration induced by fibronectin incubated with and without peroxynitrite. Peroxynitrite attenuated fibronectin-induced fibroblast migration in a dose-dependent manner but did not attenuate complement-activated serum-induced fibroblast migration. The reducing agents, deferoxamine and dithiothreitol (DTT), and L-tyrosine reversed the inhibition by peroxynitrite. PAPA-NONOate, a nitric oxide (NO) donor, and superoxide generated by the action of xanthine oxidase on lumazine or xanthine, also showed an inhibitory effect on fibroblast migration. The peroxynitrite generator, 3-morpholinosydnonimine (SIN-1), caused a concentration-dependent inhibition of fibroblast migration. Peroxynitrite reduced fibronectin binding to fibroblasts and resulted in nitrotyrosine formation. These findings are consistent with nitration of tyrosine by peroxynitrite with subsequent inhibition of fibronectin binding to fibroblasts and suggest that peroxynitrite may play a role in regulation of fibroblast migration.
authors.affiliation: Research Service, Southern Arizona Veterans Health Care System, Tucson, AZ 85723, USA.
authors.forename: E
authors.initials: E
authors.lastname: Sato
authors.forename: S
authors.initials: S
authors.lastname: Koyama
authors.forename: S L
authors.initials: SL
authors.lastname: Camhi
authors.forename: D K
authors.initials: DK
authors.lastname: Nelson
authors.forename: R A
authors.initials: RA
authors.lastname: Robbins
mesh_terms: D001769:Blood; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D003167:Complement Activation; D003676:Deferoxamine / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D004622:Embryo, Mammalian; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology*; D005353:Fibronectins / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008168:Lung; D008981:Molsidomine / Q000031:analogs & derivatives / Q000494:pharmacology; D009566:Nitrates / Q000494:pharmacology; D020030:Nitric Oxide Donors / Q000494:pharmacology; D009584:Nitrogen / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D019163:Reducing Agents / Q000494:pharmacology; D013481:Superoxides / Q000494:pharmacology; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D005353:Fibronectins; D009566:Nitrates; D020030:Nitric Oxide Donors; D017382:Reactive Oxygen Species; D019163:Reducing Agents; D013481:Superoxides; C039642:peroxynitric acid; C002744:3-nitrotyrosine; D014443:Tyrosine; C002385:linsidomine; D008981:Molsidomine; D014969:Xanthine Oxidase; D003676:Deferoxamine; D009584:Nitrogen; D004229:Dithiothreitol